Bluebird's Ali Flies To REGENXBIO
This article was originally published in Scrip
Biotech REGENXBIO Inc. has appointed Faraz Ali chief business officer. Ali joins from bluebird bio where he was vice president, head of global commercial development and external affairs. Before this he held global commercial roles at Genzyme Corporation including head of US marketing and strategic planning. He is currently chair of the Reimbursement Committee at the Alliance for Regenerative Medicine.